Minneapolis, MNNCT07649135Now EnrollingIRB Ready

Stroke Clinical Trial in Minneapolis, MN

Access cutting-edge stroke treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by University of Minnesota

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this stroke clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Stroke Study in Minneapolis

The goal of this study is to explore the feasibility of a new approach to rehabilitation that focuses on step count. Participants will complete 6 telephone or Zoom-based sessions with an occupational therapist over 6 weeks and use a step count tracker during that time. They will also complete questionnaires, assessments, surveys, and physical activity measurements during study weeks 0 (baseline), 3 (mid-point), 7 (post-intervention) and 12 (follow-up).

Sponsor: University of Minnesota

Who Can Participate

Inclusion Criteria

Stroke diagnosis confirmed by imaging
Stroke occurred 6 or more months before study enrollment
Meet criteria for "inactive" on the International Physical Activity Questionnaire-Short Form
Able to identify a support person that they interact with in-person at least once per week
Able and willing to participate fully in the study and provide informed consent or proxy consent with participant assent

Exclusion Criteria

Currently receiving care in a transitional care unit, skilled nursing facility, or other institutional care setting
Currently receiving outpatient neurorehabilitation services (e.g., physical therapy, occupational therapy, speech therapy)
Severe cognitive or communication impairments (inability to respond accurately to complete study screening questions or to provide informed consent or assent)
Currently pregnant or expecting to become pregnant in the next 8 weeks Comorbid neurological disorder (Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma, spinal cord injury, cerebral palsy)
Comorbid cancer, currently undergoing chemotherapy or radiation treatment
Received inpatient treatment or was hospitalized for a psychiatric condition and/or alcohol or substance abuse within the past 12 months
Current diagnosis of a terminal illness and/or currently receiving hospice care
History of allergic reaction to adhesives that precludes the use of an adhesive necessary for adherence to activPAL measurement
Uses wheelchair as primary mobility aid outside of home setting
Inability to speak, read, or understand English
Concurrent participation in another rehabilitation intervention research study
Resides more than 50 miles outside of the Twin Cities, Minnesota metropolitan area
Investigator discretion for safety or adherence reasons

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT07649135) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Treatment Options in Minneapolis, MN

If you're searching for stroke treatment options in Minneapolis, MN, this clinical trial (NCT07649135) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Minneapolis, MN

See all stroke clinical trials recruiting in Minneapolis — not just this study.

Browse Stroke Trials in Minneapolis →

Browse More Trials by Condition

Stroke TrialsAll Conditions →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN